Expression of Concern: Administration of supplemental l-tyrosine with phenelzine: A clinical literature review (Clin Pharmacol Adv Appl., (2014) 6, (107–110), 10.2147/CPAA.S67271);Administration of supplemental L-tyrosine with phenelzine: A clinical literature review

Clinical Pharmacology: Advances and Applications

Volumn 6, Issue 1, 2014, Pages 107-110

  Hinz, Marty ^a   Stein, Alvin ^b   Cole, Ted ^c   Ryan, Patricia ^d  

^a NeuroResearch Clinics Inc   (United States)

^b Stein Orthopedic Associates   (United States)

^c Cole Center for Healing ^*  (United States)

^d Family Wellness Center   (United States)

Author keywords

Hypertensive crisis; Phenelzine; Stroke; Tyramine; Tyrosine

Indexed keywords

DOPAMINE; LEVODOPA; MONOAMINE OXIDASE INHIBITOR; PHENELZINE; PHENYLALANINE; TRYPTOPHAN; TYRAMINE; TYROSINE;

DIET RESTRICTION; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DRUG CONTRAINDICATION; DRUG INFORMATION; DRUG METABOLISM; DRUG SAFETY; DRUG WITHDRAWAL; FOOD AND DRUG ADMINISTRATION; FOOD COMPOSITION; FOOD INTAKE; HUMAN; HYPERTENSIVE CRISIS; NONHUMAN; PEER REVIEW; PRACTICE GUIDELINE; PRESCRIPTION; REVIEW; UNITED STATES;

EID: 84904987184     PISSN: None     EISSN: 11791438     Source Type: Journal    
DOI: 10.2147/CPAA.S240229     Document Type: Erratum

References (32)

1. Dollins AB, Krock LP, Storm WF, Wurtman RJ, Lieberman HR. L-tyrosine ameliorates some effects of lower body negative pressure stress. Physiol Behav. 1995;57(2):223-230.
2. Nardil® (phenelzine) [prescribing information]. New York, USA: Pfizer, Inc. Available from: http://www.pfizer.com/files/products/uspi_nardil.pdf. Accessed June 17, 2014.
3. Kyoto Encyclopedia of Genes and Genomes (KEGG). KEGG tyrosine metabolism homo sapiens reference pathway. Available from: http://www.genome.jp/kegg-bin/show_pathway?org_name=hsa&mapno=00350&mapscale=&show_description=hide. Accessed June 17, 2104.
4. Saunders JC, Roukema RW, Kline NS, Bailey SD'A, et al. Clinical results with phenelzine. Am J Psychiatry. 1959;116:71-72.
5. Sved AF, Fernstrom JD, Wurtman RJ. L-tyrosine administration reduces blood pressure and enhances brain norepinephrine release in spontaneously hypertensive rats. Proc Natl Acad Sci U S A. 1979;76(7):3511-3514.
6. Deijen J, Orlebeke JF. Effect of L-tyrosine on cognitive function and blood pressure under stress. Brain Res Bull. 1994;33:319-323.
7. Bresnahan MR, Hatzinikolaou P, Brunner HR, Gavras H. Effects of L-tyrosine infusion in normotensive and hypertensive rats. Am J Physiol. 1980;239(2):H206-H211.
8. Ekholm S, Karppanen H. Cardiovascular effects of L-tyrosine in normotensive and hypertensive rats. Eur J Pharmacol. 1987;143(1): 27-34.
9. Deijen J, Wientjes CJE, Vullinghs HFM, Cloin PA, Langefeld JJ. L-tyrosine improves cognitive performance and reduces blood pressure in cadets after one week of a combat training course. Brain Res Bull. 1999;48(2):203-209.
10. Yamori Y, Fujiwara M, Horie R, Lovenberg W. The hypotensive effect of centrally administered L-tyrosine. Eur J Pharmacol. 1980;68(2): 201-204.
11. Glaeser BS, Melamed E, Growdon JH, Wurtman RJ. Elevation of plasma L-tyrosine after a single oral dose of L-tyrosine. Life Sci. 1979;25(3):265-271.
12. Black J, Waeber B, Bresnahan MR, Gavras I, Gavras H. Blood pressure response to central and/or peripheral inhibition of phenylethanolamine N-methyltransferase in normotensive and hypertensive rats. Circ Res. 1981;49(2):518-524.
13. United States Department of Agriculture (USDA). USDA nutrient database. Available http://rom:nal.usda.gov/ndb/nutrients/report/nutrientsfrm?max=25&offset=0&totCount=0&nutrient1=509&nutrient2=&nutrient3=&subset=0&fg=&sort=f&measureby=m. Last accessed June 29, 2014.
14. US Food and Drug Administration (FDA). FDA guidance on phenelzine sulfate. Available from: www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm209250.pdf. Accessed April 26, 2014.
15. Trachte G, Uncini T, Hinz M. Both stimulatory and inhibitory effects of dietary 5-hydroxytryptophan and tyrosine are found on urinary excretion of serotonin and dopamine in a large human population. Neuropsychiatr Dis Treat. 2009;5:227-235.
16. Hinz M. Depression. In: Kohlstadt I, editor. Food and Nutrients in Disease Management. Boca Raton, FL: CRC Press; 2009:465-481.
17. Hinz M, Stein A, Uncini T. The dual-gate lumen model of renal monoamine transport. Neuropsychiatr Dis Treat. 2010;6:387-392.
18. Hinz M, Stein A Trachte G, Uncini T. Neurotransmitter testing of the urine: a comprehensive analysis. Open Access J Urol. 2010;2: 177-183.
19. Hinz M, Stein A, Uncini T. A pilot study differentiating recurrent major depression from bipolar disorder cycling on the depressive pole. Neuropsychiatr Dis Treat. 2010;6:741-747.
20. Stein A, Hinz M, Uncini T. Amino acid responsive Crohn's disease: a case study. Clin Exp Gastroenterol. 2010;3:171-177.
21. Hinz M, Stein A, Uncini T. Treatment of attention deficit hyperactivity disorder with monoamine amino acid precursors and organic cation transporter assay interpretation. Neuropsychiatr Dis Treat. 2011;7:31-38.
22. Hinz M, Stein A, Uncini T. Urinary neurotransmitter testing: considerations of spot baseline norepinephrine and epinephrine. Open Access J Urol. 2011;3:19-24.
23. Hinz M, Stein A, Uncini T. Amino acid management of Parkinson disease: a case study. Int J Gen Med. 2011;4:1-10.
24. Hinz M, Stein A, Uncini T. Validity of urinary monoamine assay sales under the "spot baseline urinary neurotransmitter testing marketing model". Int J Nephrol Renovasc Dis. 2011;4:101-113.
25. Hinz M, Stein A, Uncini T. APRESS: apical regulatory super system, serotonin, and dopamine interaction. Neuropsychiatr Dis Treat. 2011;7:1-7.
26. Hinz M, Stein A, Uncini T. Monoamine depletion by reuptake inhibitors. International Drug, Healthcare and Patient Safety. 2011;3:69-77.
27. Hinz M, Stein A, Uncini T. The discrediting of the monoamine hypothesis. Int J Gen Med. 2012;5:135-142.
28. Hinz M, Stein A, Uncini T. Relative nutritional deficiencies associated with centrally acting monoamines. Int J Gen Med. 2012;5:413-430.
29. Hinz M, Stein A, Uncini T. 5-HTP efficacy and contraindications. Int J Gen Med. 2012;5:413-430.
30. Boulton AA, Cookson B, Paulton R. Hypertensive crisis in a patient on MAOI antidepressants following a meal of beef liver. Can Med Assoc J. 1970;102(13):1394-1395.
31. Horwitz D, Lovenberg W, Engelman K, Sjoerdsma A. Monoamine oxidase inhibitors, tyramine, and cheese. JAMA. 1964;188(13):1108-1110.
32. Shulman KI, Walker SE, MacKenzie S, Knowles S. Dietary restriction, tyramine, and the use of monoamine oxidase inhibitors. J Clin Psychopharmacol. 1989;9(6):397-402.